logo

Redx Pharma - Capital Network: Entering the Clinical Stage

Written by Riccardo Lowi

Redx Pharma (REDX.LON), a drug discovery and development company focused on oncology, immunology and infectious diseases, is about to move its two lead candidates into the clinical stage.

Redx pharma (REDX.LON) owns RXC005 global IP rights, with key composition-of-matter patents expected to extend up until 2035

FULL REPORT CONTINUES…

Latest Research